Zerlasiran
- Profiles in Catholicism
- Apr 10, 2024
- 1 min read
Medical Journal Articles
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial by Steven E. Nissen, MD, Kathy Wolski, MPH, Gerald F. Watts, MD, DSc, et al. JAMA April 8, 2024
